Atlas Venture Opportunity Fund I L.P. 13D/13G Filings for F-star Therapeutics, Inc. (FSTX)

Atlas Venture Opportunity Fund I L.P. 13D and 13G filings for F-star Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
5:42 pm
Unchanged		 2021-12-31 13G F-star Therapeutics, Inc.
FSTX		 Atlas Venture Opportunity Fund I L.P. 599,524
2.900%		 0
(Unchanged)		 Filing
2021-02-03
5:14 pm
Purchase		 2020-11-20 13G F-star Therapeutics, Inc.
FSTX		 Atlas Venture Opportunity Fund I L.P. 599,524
6.600%		 599,524increase
(New Position)		 Filing